NSF HOPES TO BOOST ITS SUPPORT FOR INDIVIDUAL GRANTS

Volume 5, #5The Scientist March 4, 1991 NSF HOPES TO BOOST ITS SUPPORT FOR INDIVIDUAL GRANTS Author: Jeffrey Mervis Date: March 4, 1991 WASHINGTON--There's more for individual investigators in the 1992 proposed budget for the National Science Foundation. But whether that translates into bigger grants or more awards, should the money still be there in the fall when Congress completes action on the federal budget, is a question that NSF officials expect to be answered individual

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON--There's more for individual investigators in the 1992 proposed budget for the National Science Foundation. But whether that translates into bigger grants or more awards, should the money still be there in the fall when Congress completes action on the federal budget, is a question that NSF officials expect to be answered individually by the foundation's five research directorates.

The president's overall request for $2.72 billion--an increase of $406 million, or 17.5 percent--for the agency contains the usual array of offerings for scientists. About half of the $270 million boost in research should be available to program managers to fund additional investigator-initiated research, estimates acting NSF director Fred Bernthal. In addition, he says, most of the specially targeted programs will end up supporting individual scientists.

The NSF budget is sprinkled with such new initiatives, some open to all fields and others aimed at a specific subdiscipline. A $50 million program ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies